difference between semaglutide and peptides A new era for oral peptides: SNAC the development of oral for the treatment of type 2 diabetes | Reviews in Endocrine and Metabolic Disorders Peptides vs GLP-1 (Ozempic): Are

This is a counseling point clinicians will need to flag routinely

Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria

Medication preparation, inventory availability, compounding processes, and shipping timelines are controlled by licensed pharmacies

#PharmaNews #PharmaResults #EarningsUpdate #IndianPharma #PharmaUpdates #Harshal #PharmawithHJ #HJ Gland Pharma FY25 Results: Strong Margins, 31 Product Launches Gland Pharma Limited FY25 Results: Margins Hold Strong, Strategy Gathers Steam Financial Highlights: - FY25 Revenue: 5,617 Cr (1% YoY) - EBITDA Margin: 1,269 Cr (5% YoY) | Margin 23% - PAT: 698 Cr (10% YoY) | Margin at 12% - Dividend: 18/share final dividend recommended Business Highlights: - 31 product launches in FY25, including new molecules like Latanoprost & Dexamethasone - 32 ANDA approvals, 24 filings U.S